New shot for babies aims to block dangerous RSV virus
NCT ID NCT07363837
Summary
This early-stage trial is testing a new injection called SIBP-A16 to see if it can help prevent serious illness from Respiratory Syncytial Virus (RSV) in babies. The study will enroll 36 premature and full-term infants to check the safety of different doses and see how the body processes the drug. Researchers will compare the new injection against a placebo and an existing treatment to measure the immune response it creates against RSV.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RESPIRATORY SYNCYTIAL VIRUS (RSV) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
West China Second Hospital, Sichuan University
Chengdu, Sichuan, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.